Ortin Global Limited (BOM:539287)
15.00
-0.25 (-1.64%)
At close: Sep 25, 2026
Ortin Global Revenue
Ortin Global had revenue of 160.00K INR in the quarter ending June 30, 2026, a decrease of -59.80%. This brings the company's revenue in the last twelve months to 356.00K, down -79.47% year-over-year. In the fiscal year ending March 31, 2026, Ortin Global had annual revenue of 1.08M, down -68.35%.
Revenue (ttm)
356.00K
Revenue Growth
-79.47%
P/S Ratio
342.61
Revenue / Employee
44.50K
Employees
8
Market Cap
121.97M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.08M | -2.34M | -68.35% |
| Mar 31, 2025 | 3.43M | -18.84M | -84.61% |
| Mar 31, 2024 | 22.26M | -38.08M | -63.11% |
| Mar 31, 2023 | 60.34M | -21.97M | -26.69% |
| Mar 31, 2022 | 82.31M | 633.62K | 0.78% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Add-Shop E-Retail | 1.71B |
| Beryl Drugs | 213.23M |
| Unjha Formulations | 152.79M |
| Zenith Healthcare | 108.46M |
| Hamps Bio | 84.75M |
| Norris Medicines | 76.00M |
| Desh Rakshak Aushdhalaya | 66.33M |
| Colinz Laboratories | 58.11M |